10/21/2025 08:00
Impartner Expands European Infrastructure to Accelerate Growth and Customer Support Across EMEA

Impartner, the leading provider of Partner Relationship Management (PRM) solutions, today announced the expansion of its European infrastructure with a new Azure-based data centre in the Netherlands. This milestone reflects Impartner’s accelerating success across the EMEA region and its commitment to providing customers with the highest levels of security, compliance, performance and support. “Our EMEA business continues to grow rapidly as companies across the region look to Impartner to scal...

10/21/2025 08:00
NTT DATA Strengthens Global Insurance Leadership with Acquisition of Alchemy Technology Services

NTT DATA, a global leader in AI, digital business and technology services, today announced the acquisition of Alchemy Technology Services, a specialist insurance technology consultancy. The move reinforces NTT DATA’s commitment to transforming the global insurance ecosystem, addressing current and emerging challenges around agility, modernization and scalability. In addition to its strong consultancy and Guidewire credentials, Alchemy brings deep expertise in the specialty insurance market, par...

10/21/2025 08:51
Polpharma Biologics announces commercial launch of Europe’s first Pre-filled Syringe presentation of a ranibizumab biosimilar

Polpharma Biologics today announced Ranivisio® PFS (ranibizumab biosimilar pre-filled syringe), is now commercially available in France. Ranivisio® is the first Lucentis® biosimilar which is offered in a convenient pre-filled syringe (PFS) presentation in Europe, setting a new standard for affordable biologics in ophthalmic care. This innovative configuration provides precise dosing and ease of use, supporting efficient administration for patients with neovascular (wet) age-related macular de...

10/21/2025 09:12
Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

Spanish international pharmaceutical company Ferrer has announced the completion of patient recruitment for the PROSPER study, a Phase II clinical trial designed to assess the efficacy, safety, and pharmacokinetics of FNP-223, an orally available, potent and selective inhibitor of the OGA enzyme, in-licensed from Asceneuron, aimed at slowing disease progression in Progressive Supranuclear Palsy (PSP)1. This press release features multimedia. View the full release here: https://www.businesswire...

10/21/2025 10:00
IFF and BASF Announce Strategic Collaboration to Drive Next-Generation Enzyme and Polymer Innovation

IFF (NYSE: IFF) — a global leader in flavors, fragrances, food ingredients, health and biosciences — announced a strategic collaboration with BASF, one of the world’s largest chemical companies and leader in sustainable product innovation, to accelerate the development of IFF’s Designed Enzymatic Biomaterials™ technology platform and create next-generation enzyme technologies for fabric, dish and personal care as well as industrial cleaning applications. This press release features multimedia....

AFP statement on brief detention of journalist in Nigeria

On October 20, 2025, police in Nigeria briefly detained AFP video journalist John Okunyomih outside the Transcorp Hilton Hotel in the capital Abuja.

On October 20, 2025, police in Nigeria briefly detained AFP video journalist John Okunyomih outside the Transcorp Hilton Hotel in the capital Abuja.
11/11/2025 14:00
Financial Sector Signals Rising Investment in Identity Verification

Banks, fintechs, and crypto platforms are ramping up investment in fraud prevention and identity verification (IDV), positioning it as the next layer of cyber defense. According to Regula’s global survey, The Future of Identity Verification: 5 Threats and 5 Opportunities, banks are leading this trend: the share of institutions intending to increase IDV budgets by more than 50% is nearly tripling—from 4.4% to 15% in just two years. This press release features multimedia. View the full release h...

11/11/2025 14:00
Ben Mauro Announces Early Deluxe Hardcover Release of HUXLEY: The Oracle, Featuring Exclusive Art From Top Sci-Fi Artists

Acclaimed concept artist and worldbuilder Ben Mauro (Halo Infinite, Call of Duty, Elysium, The Predator) is excited to announce the early shipping of the deluxe hardcover edition of HUXLEY: The Oracle, the first major prequel book in the expanding HUXLEY universe. These premium deluxe editions are shipping now in limited quantities, ahead of the worldwide release of the standard edition on December 2. This press release features multimedia. View the full release here: https://www.businesswire.c...

11/11/2025 14:01
Blue Matter Enhances Twine™ Platform Capabilities in Response to Growing Demand

Blue Matter today announced the expansion of its Twine™ data platform’s capabilities in response to accelerating demand from biopharma companies. Enhancements include thoughtful use of artificial intelligence (AI) for advanced analytics and narratives, expanded data source integrations, master data management, and broader deployment across oncology and specialty therapeutic areas. Twine™ is Blue Matter's purpose-built customer intelligence platform for healthcare and life sciences companies. I...

11/11/2025 14:02
ThreatDown Launches Nexus Partner Program, Strengthening its Channel-First Commitment

ThreatDown, the corporate business unit of Malwarebytes, today announced the launch of the Nexus Partner Program, a comprehensive initiative that puts partners at the center by strengthening collaboration and creating new growth opportunities for its global network of partners. The program aligns incentives, simplifies enablement, and strengthens collaboration to ensure every reseller has the resources and support needed to deliver smarter, stronger security outcomes for customers. “At Threat...